Article Text
Statistics from Altmetric.com
Introduction
The following is a summary of the British Thoracic Society (BTS) Guideline for pleural disease and includes a summary of the guideline recommendations and good practice points (GPPs). The full guideline is published as a separate Thorax Supplement1 and is available from the BTS website.2 Please refer to the full guideline for full information about each section.1 All online supplemental appendices are also available via the BTS website.2
Background
The aim of the guideline was to provide evidence-based guidance on the investigation and management of pleural disease. Pleural disease is common and represents a major and rapidly developing subspecialty that presents to many different hospital services. Since the last BTS Guideline for pleural disease published in 2010,3–9 many high quality and practice changing studies, using patient centred outcomes, have been published. The paradigms for the investigation and management of pleural disease have therefore shifted, so this guideline aimed to capture this evidence and use it to answer the most important questions relevant to today’s practice.
Target audience for the guideline
The guideline will be of interest to UK based clinicians caring for adults with pleural disease, including chest physicians, respiratory trainees, specialist respiratory nurses, specialist lung cancer nurses, specialist pleural disease nurses, pathologists, thoracic surgeons, thoracic surgeon trainees, acute physicians, oncologists, emergency physicians, hospital practitioners, intensive care physicians, palliative care physicians, radiologists, other allied health professional and patients and carers.
Areas covered by the guideline
The guideline focuses on the investigation and management of pleural disease in adults and covers four broad areas of pleural disease:
Spontaneous pneumothorax
Undiagnosed unilateral pleural effusion
Pleural infection
Pleural malignancy
Adult patients in both inpatient and ambulatory settings are considered.
The guideline does not cover mesothelioma (as alternative guidance is available10), benign (non-infectious, non-pneumothorax) pleural disease or rare pleural diseases. Guidance on pleural interventions is also covered in the …
Linked Articles
- Editorial
- BTS Guideline